Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.44 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9120165 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL28239993 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL5678381 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL8921629 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL4959403 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL1543206 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL904359 | 1.00 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL6434907 | 0.98 | FFAR1 (0.52) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL27461812 | 0.95 | FFAR4 (0.50) | FFAR1FFAR4GPR84NFKB1FDPS | |
| SCHEMBL16431765 | 0.91 | FFAR1 (0.55) | FFAR1FFAR4GPR84NFKB1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2960258-B1 | UV-curable acrylic copolymers | HENKEL AG & CO KGAA (DE) | 2018-08-22 | — | — | EP | claimed |
| EP-0675141-B2 | Copolymer compositions containing hydroxyl functional (meth)acrylates and hydroxyalkyl carbamate (meth)acrylates and mixtures thereof | UNION CARBIDE CHEM PLASTIC (US) | 2004-09-29 | — | — | EP | claimed |
| EP-0675141-B1 | Copolymer compositions containing hydroxyl functional (meth)acrylates and hydroxyalkyl carbamate (meth)acrylates and mixtures thereof | UNION CARBIDE CHEM PLASTIC (US) | 1998-06-03 | — | — | EP | claimed |
| EP-0281360-B1 | HYDROPHOBICALLY MODIFIED NON-IONIC POLYGALACTOMANNAN ETHERS | STEIN, HALL & CO., INC. (US) | 1993-09-01 | — | — | EP | claimed |
| US-20240228799-A1 | NON-HAZARDOUS MONOMERS AS REACTIVE DILUENTS FOR RESINS | ELANTAS EUROPE GMBH (DE) | 2024-07-11 | — | — | US | disclosed |
| EP-4337634-A1 | NON-HAZARDOUS MONOMERS AS REACTIVE DILUENTS FOR RESINS | Elantas Europe GmbH (DE) | 2024-03-20 | — | — | EP | disclosed |
| US-20220202683-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2022-06-30 | — | — | US | disclosed |
| EP-3946241-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-02-09 | — | — | EP | disclosed |
| CN-113677317-A | Increasing the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2021-11-19 | — | — | CN | disclosed |
| WO-2020200546-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | HENKEL AG & CO. KGAA (DE) | 2020-10-08 | — | — | WO | disclosed |
| EP-2375278-B1 | COMPOSITION FOR FORMING LIQUID CRYSTAL ALIGNMENT FILM | SHARP KK (JP) | 2020-04-08 | — | — | EP | disclosed |
| US-9803161-B2 | Cleaning agent for semiconductor substrates and method for processing semiconductor substrate surface | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| CN-1575236-A | Imide compounds and optical recording media made by using the same | MITSUI CHEMICALS INC OGISO AKI (JP) | 2005-02-02 | — | — | CN | disclosed |
| CN-1434771-A | Optical recording medium and azaporphyrin compound | MITSUI CHEMICALS INC (JP) | 2003-08-06 | — | — | CN | disclosed |
| US-6586106-B2 | Ink transfer, adhesion and aging stability, and being satisfactory in back ghost when offset printing using oxidation polymerization type ink is performed on both faces | YUPO CORPORATION (JP) | 2003-07-01 | — | — | US | disclosed |
| CN-1406182-A | Benzodiazolyl compound, optical recording medium compound | MITSUI CHEMICALS INC (JP) | 2003-03-26 | — | — | CN | disclosed |
| US-20020054991-A1 | Thermoplastic resin film satisfactory in printability | YUPO CORPORATION (JP) | 2002-05-09 | — | — | US | disclosed |
| CN-1338738-A | Optical recording media and porphinoid compound | MITSUI CHEMICALS INC (JP) | 2002-03-06 | — | — | CN | disclosed |
| EP-1172400-A1 | THERMOPLASTIC RESIN FILM WITH SATISFACTORY PRINTABILITY | Yupo Corporation (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-4590291-A | Thrombin inhibitory new dihydroxybenzene ether derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1986-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220202683-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | KRT18, CCNO, AKR1B10 | FFAR1 3516/4885FFAR4 4753/4885GPR84 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.